While these data suggest that BATF2 may be upregulated as a compensatory mechanism to regulate cyclin D1 in GBM, overall cyclin D1 levels were still elevated in GBM samples compared with human astrocyte controls. This evidence concerns the gene BATF2 and glioblastoma.